{
    "clinical_study": {
        "@rank": "148071", 
        "arm_group": {
            "arm_group_label": "Chronic HBV", 
            "description": "chronic HBV strata: HBV tolerant, Chronic active HBe+ or HBe-, suppressed with antiviral therapy"
        }, 
        "biospec_descr": {
            "textblock": "plasma/serum PBMC"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The objective of the study is to procure blood (plasma, serum, RNA and PBMC samples) from\n      approximately 40 chronic HBV for biomedical research program led by VGTI Florida."
        }, 
        "brief_title": "Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Hepatitis B", 
        "condition_browse": {
            "mesh_term": [
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis B", 
                "Hepatitis, Chronic", 
                "Hepatitis B, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "During chronic HBV infection, a dynamic balance between viral replication and the host\n      immune response is pivotal to the pathogenesis of liver disease. HBV specific T-cell\n      function is impaired in patients with chronic HBV infection characterized by low levels of\n      antiviral cytokines, impaired cytotoxic T lymphocyte activity, and persistent viremia.\n      However, the mechanism underlying this T-cell malfunction in chronic HBV infection has not\n      been completely understood.\n\n      The biomedical research on the samples obtained during this study will include, among other\n      studies, advanced flow cytometry to study the Treg and activation markers, negative\n      regulatory molecules and phenotype of CD4 and CD8 subsets using the extended panel markers\n      developed at VGTI Florida. Additional antibody panels for measuring functional CD4 responses\n      by ICS, DC subsets, activation, and signaling pathways by phos"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient with chronic HBV infection documented by presence of HBsAg for at least 12\n             months currently untreated for HBV infection or under stable antiviral therapy\n\n        Exclusion Criteria:\n\n          -  Prior use of HBV therapeutic vaccine\n\n          -  Currently treated with interferon alpha or other immune modulator(s)\n\n          -  Acute HBV infection\n\n          -  Chronic inactive HBV carrier\n\n          -  under an acute flare/reactivation of HBV infection defined as symptoms of acute\n             hepatitis and recent elevation of aminotransferase (over 10 x ULN) or bilirubin\n             levels\n\n          -  Known co-infection with HCV, HDV, and/or HIV\n\n          -  Under renal dialysis\n\n          -  For female patients, pregnant or breastfeeding\n\n          -  Cirrhosis, hepatocellular carcinoma or liver transplantation\n\n          -  active autoimmune disease including autoimmune hepatitis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients volunteers"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02017587", 
            "org_study_id": "HBV-001"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 16, 2013", 
        "location": {
            "contact": {
                "email": "pgsmith@vcu.edu", 
                "last_name": "Paula G Smith, RN"
            }, 
            "facility": {
                "address": {
                    "city": "Richmond", 
                    "country": "United States", 
                    "state": "Virginia", 
                    "zip": "23298"
                }, 
                "name": "Virginia Commonwealth University Health System"
            }, 
            "investigator": {
                "last_name": "Richard sterling, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV Infection", 
        "overall_contact": {
            "email": "pyeramian@vgtifl.org", 
            "last_name": "Patrick D Yeramian, MD", 
            "phone": "772 345 5669"
        }, 
        "overall_official": {
            "affiliation": "Virginia Commonwealth University Health System", 
            "last_name": "Richard Sterling, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Phenotype CD4+ and CD8+ subsets - activation markers and negative regulators - CD4+ functional response. Expression of programmed death 1 (PD-1) and its ligand (PD-L1/B7-H1) on viral antigen-specific T-cells", 
            "measure": "T lymphocyte phenotype and functional response in chronic HBV infection", 
            "safety_issue": "No", 
            "time_frame": "Baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02017587"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Vaccine and Gene Therapy Institute, Florida", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vaccine and Gene Therapy Institute, Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}